APA (7th ed.) Citation

Tinning, A. R., Bengtsen, C., Jensen, N. V., Bastholt, L., Jensen, B. L., & Madsen, K. (2018). Pazopanib-Induced Hypertension in Patients With Renal Cell Carcinoma Is Associated With Low Urine Excretion of NO Metabolites. Hypertension (0194911X), 71(3), 473. https://doi.org/10.1161/HYPERTENSIONAHA.117.10225

Chicago Style (17th ed.) Citation

Tinning, Anne Robdrup, Camilla Bengtsen, Niels Viggo Jensen, Lars Bastholt, Boye Lagerbon Jensen, and Kirsten Madsen. "Pazopanib-Induced Hypertension in Patients With Renal Cell Carcinoma Is Associated With Low Urine Excretion of NO Metabolites." Hypertension (0194911X) 71, no. 3 (2018): 473. https://doi.org/10.1161/HYPERTENSIONAHA.117.10225.

MLA (9th ed.) Citation

Tinning, Anne Robdrup, et al. "Pazopanib-Induced Hypertension in Patients With Renal Cell Carcinoma Is Associated With Low Urine Excretion of NO Metabolites." Hypertension (0194911X), vol. 71, no. 3, 2018, p. 473, https://doi.org/10.1161/HYPERTENSIONAHA.117.10225.